We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay Ahead of the Game With H. B. Fuller (FUL) Q3 Earnings: Wall Street's Insights on Key Metrics
Read MoreHide Full Article
In its upcoming report, H. B. Fuller (FUL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.46 per share, reflecting an increase of 15.9% compared to the same period last year. Revenues are forecasted to be $940.38 million, representing a year-over-year increase of 5.4%.
The consensus EPS estimate for the quarter has been revised 1.9% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some H. B. Fuller metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Revenue- Hygiene, Health and Consumable Adhesives' at $405.74 million. The estimate suggests a change of +5.1% year over year.
The consensus estimate for 'Net Revenue- Engineering Adhesives' stands at $279.86 million. The estimate points to a change of +2.8% from the year-ago quarter.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Engineering Adhesives' will likely reach $65.17 million. The estimate compares to the year-ago value of $63.43 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Building Adhesive Solutions' should arrive at $44.08 million. Compared to the present estimate, the company reported $41.47 million in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted EBITDA- Hygiene, Health and Consumable Adhesives' should come in at $71.86 million. The estimate compares to the year-ago value of $65.32 million.
Over the past month, H. B. Fuller shares have recorded returns of -14.8% versus the Zacks S&P 500 composite's -1.3% change. Based on its Zacks Rank #3 (Hold), FUL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Stay Ahead of the Game With H. B. Fuller (FUL) Q3 Earnings: Wall Street's Insights on Key Metrics
In its upcoming report, H. B. Fuller (FUL - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $1.46 per share, reflecting an increase of 15.9% compared to the same period last year. Revenues are forecasted to be $940.38 million, representing a year-over-year increase of 5.4%.
The consensus EPS estimate for the quarter has been revised 1.9% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
That said, let's delve into the average estimates of some H. B. Fuller metrics that Wall Street analysts commonly model and monitor.
The average prediction of analysts places 'Net Revenue- Hygiene, Health and Consumable Adhesives' at $405.74 million. The estimate suggests a change of +5.1% year over year.
The consensus estimate for 'Net Revenue- Engineering Adhesives' stands at $279.86 million. The estimate points to a change of +2.8% from the year-ago quarter.
The combined assessment of analysts suggests that 'Adjusted EBITDA- Engineering Adhesives' will likely reach $65.17 million. The estimate compares to the year-ago value of $63.43 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- Building Adhesive Solutions' should arrive at $44.08 million. Compared to the present estimate, the company reported $41.47 million in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted EBITDA- Hygiene, Health and Consumable Adhesives' should come in at $71.86 million. The estimate compares to the year-ago value of $65.32 million.
View all Key Company Metrics for H. B. Fuller here>>>Over the past month, H. B. Fuller shares have recorded returns of -14.8% versus the Zacks S&P 500 composite's -1.3% change. Based on its Zacks Rank #3 (Hold), FUL will likely exhibit a performance that aligns with the overall market in the upcoming period. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .